240 related articles for article (PubMed ID: 28441455)
1. Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer.
Companioni O; Sanz-Anquela JM; Pardo ML; Puigdecanet E; Nonell L; García N; Parra Blanco V; López C; Andreu V; Cuatrecasas M; Garmendia M; Gisbert JP; Gonzalez CA; Sala N
PLoS One; 2017; 12(4):e0176043. PubMed ID: 28441455
[TBL] [Abstract][Full Text] [Related]
2. Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer.
Rosania R; Varbanova M; Wex T; Langner C; Bornschein J; Giorgio F; Ierardi E; Malfertheiner P
BMC Gastroenterol; 2017 Jun; 17(1):84. PubMed ID: 28662697
[TBL] [Abstract][Full Text] [Related]
3. SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer.
Companioni Nápoles O; Tsao AC; Sanz-Anquela JM; Sala N; Bonet C; Pardo ML; Ding L; Simo O; Saqui-Salces M; Blanco VP; Gonzalez CA; Merchant JL
J Gastroenterol; 2017 Jan; 52(1):39-49. PubMed ID: 27032393
[TBL] [Abstract][Full Text] [Related]
4. Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow-up multicenter study.
González CA; Sanz-Anquela JM; Companioni O; Bonet C; Berdasco M; López C; Mendoza J; Martín-Arranz MD; Rey E; Poves E; Espinosa L; Barrio J; Torres MÁ; Cuatrecasas M; Elizalde I; Bujanda L; Garmendia M; Ferrández Á; Muñoz G; Andreu V; Paules MJ; Lario S; Ramírez MJ; ; Gisbert JP
J Gastroenterol Hepatol; 2016 May; 31(5):953-8. PubMed ID: 26630310
[TBL] [Abstract][Full Text] [Related]
5. The Transition from Gastric Intestinal Metaplasia to Gastric Cancer Involves
Gingold-Belfer R; Kessler-Icekson G; Morgenstern S; Rath-Wolfson L; Zemel R; Boltin D; Levi Z; Herman-Edelstein M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069715
[TBL] [Abstract][Full Text] [Related]
6. Expression of GCRG213p, LINE-1 endonuclease variant, significantly different in gastric complete and incomplete intestinal metaplasia.
Duan X; Lian H; Li J; Wu B; Wang W; Wu T; Wang C; Dou Y; Zhou Z; Wang B; Xue L; Wang G
Diagn Pathol; 2019 Jun; 14(1):61. PubMed ID: 31221180
[TBL] [Abstract][Full Text] [Related]
7. Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression.
Huang KK; Ma H; Chong RHH; Uchihara T; Lian BSX; Zhu F; Sheng T; Srivastava S; Tay ST; Sundar R; Tan ALK; Ong X; Lee M; Ho SWT; Lesluyes T; Ashktorab H; Smoot D; Van Loo P; Chua JS; Ramnarayanan K; Lau LHS; Gotoda T; Kim HS; Ang TL; Khor C; Lee JWJ; Tsao SKK; Yang WL; Teh M; Chung H; So JBY; Yeoh KG; Tan P;
Cancer Cell; 2023 Dec; 41(12):2019-2037.e8. PubMed ID: 37890493
[TBL] [Abstract][Full Text] [Related]
8. CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia.
Koulis A; Di Costanzo N; Mitchell C; Lade S; Goode D; Busuttil RA; Boussioutas A
BMC Gastroenterol; 2022 Apr; 22(1):197. PubMed ID: 35448971
[TBL] [Abstract][Full Text] [Related]
9. DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia.
Krishnan V; Lim DXE; Hoang PM; Srivastava S; Matsuo J; Huang KK; Zhu F; Ho KY; So JBY; Khor C; Tsao S; Teh M; Fock KM; Ang TL; Jeyasekharan AD; Tan P; Yeoh KG; Ito Y
Gut; 2020 Oct; 69(10):1738-1749. PubMed ID: 31937549
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic implications of genetic instability in intestinal-type gastric cancer and intestinal metaplasia as a precancerous lesion: proof of field cancerization in the stomach.
Zaky AH; Watari J; Tanabe H; Sato R; Moriichi K; Tanaka A; Maemoto A; Fujiya M; Ashida T; Kohgo Y
Am J Clin Pathol; 2008 Apr; 129(4):613-21. PubMed ID: 18343789
[TBL] [Abstract][Full Text] [Related]
11. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence.
González CA; Sanz-Anquela JM; Gisbert JP; Correa P
Int J Cancer; 2013 Sep; 133(5):1023-32. PubMed ID: 23280711
[TBL] [Abstract][Full Text] [Related]
12. [Expression of intestine-specific transcription factor CDX2 in different subtypes of intestinal metaplasia and gastric carcinoma].
Liu GS; Gong J; Cheng P; Zhang J; Chang Y; Qiang L
Ai Zheng; 2006 Feb; 25(2):185-9. PubMed ID: 16480583
[TBL] [Abstract][Full Text] [Related]
13. Expression of TERT in precancerous gastric lesions compared to gastric cancer.
Duarte MC; Babeto E; Leite KR; Miyazaki K; Borim AA; Rahal P; Silva AE
Braz J Med Biol Res; 2011 Feb; 44(2):100-4. PubMed ID: 21180888
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia.
Tsukamoto T; Inada K; Tanaka H; Mizoshita T; Mihara M; Ushijima T; Yamamura Y; Nakamura S; Tatematsu M
J Cancer Res Clin Oncol; 2004 Mar; 130(3):135-45. PubMed ID: 14655050
[TBL] [Abstract][Full Text] [Related]
15. Pseudopyloric Metaplasia Is Not Associated With the Development of Gastric Cancer.
Dilaghi E; Baldaro F; Pilozzi E; Conti L; Palumbo A; Esposito G; Annibale B; Lahner E
Am J Gastroenterol; 2021 Sep; 116(9):1859-1867. PubMed ID: 34313623
[TBL] [Abstract][Full Text] [Related]
16. Role of p53 in the progression of gastric cancer.
Busuttil RA; Zapparoli GV; Haupt S; Fennell C; Wong SQ; Pang JM; Takeno EA; Mitchell C; Di Costanzo N; Fox S; Haupt Y; Dobrovic A; Boussioutas A
Oncotarget; 2014 Dec; 5(23):12016-26. PubMed ID: 25427447
[TBL] [Abstract][Full Text] [Related]
17. The expression of protein inhibitor of activated signal transducers and activators of transcription 3 in the evolutionary process of gastric cancer.
Liu LM; Yan MG; Yang DH; Sun WW; Zhang JX
Eur J Intern Med; 2011 Oct; 22(5):e31-5. PubMed ID: 21925039
[TBL] [Abstract][Full Text] [Related]
18. CEACAM5 and TROP2 define metaplastic and dysplastic transitions in human antral gastric precancerous lesions and tumors.
Jang B; Lee SH; Dovirak I; Kim H; Srivastava S; Teh M; Yeoh KG; So JB; Tsao SKK; Khor CJ; Ang TL; Goldenring JR
Gastric Cancer; 2024 Mar; 27(2):263-274. PubMed ID: 38221567
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin E and subtypes of intestinal metaplasia in carcinogenesis of the human stomach.
Lin CK; Lai KH; Lo GH; Cheng JS; Hsu PI; Mok KT; Tseng HH
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jun; 64(6):331-6. PubMed ID: 11534800
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles of histone modification genes in gastric cancer progression.
Orenay-Boyacioglu S; Kasap E; Gerceker E; Yuceyar H; Demirci U; Bilgic F; Korkmaz M
Mol Biol Rep; 2018 Dec; 45(6):2275-2282. PubMed ID: 30250993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
